Highlights Hefei Lifeon Pharmaceutical Co., Ltd.

Equities

003020

CNE100004BD9

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 04/06/2024 am IST			5-day change	1st Jan Change
21.35 ^CNY	+0.76%		+0.52%	-8.99%

21/05	Lifeon Pharmaceutical's Unit Gets Marketing Authorization for Loxoprofen Sodium Oral Solution	MT
29/04	Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lifeon Pharmaceutical's Unit Gets Marketing Authorization for Loxoprofen Sodium Oral Solution	21/05	MT
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	16/05	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	22/04	CI
Lifeon Pharmaceutical Gets Chinese Drug Regulator's Nod to Market Doxazosin Mesylate	07/12	MT
Hefei Lifeon Pharmaceutical Co., Ltd., Hefei Xinchen Enterprise Management Consulting Co., Ltd., Li Chao and Deng Xiaojuan agreed to acquire Hefei Noratech Pharmaceuticals Co., Ltd. from Roaring Success Ltd and Hefei Xinchen Enterprise Management Consulting Co., Ltd. for CNY 72 million.	31/23/31	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Hefei Lifeon Pharmaceutical Co., Ltd. signed equity transfer agreement to acquire 51% stake in Anhui Joyfar Pharmaceutical Co. Ltd. from Beijing Huixu Jintong Investment Center (Limited Partnership), Beijing Huixu Jintai Investment Center (Limited Partnership), Gong Tonglin, Shen Jun, Zhao Shoutian and Ouyang Hanlin for approximately CNY 220 million.	29/23/29	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Declares Cash Dividend on A Shares for 2022, Payable on May 24, 2023	18/23/18	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	10/23/10	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022	19/23/19	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/23/17	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/23/17	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/22/30	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	26/22/26	CI
Pingtan Wenzhou Ruiji Investment Partnership Enterprise and Zhuzhou Wenzhou Junzhe Venture Capital Partnership Enterprise (L.P.) managed by Shanghai Wenzhou Investment Management Co., Ltd. completed the acquisition of 4.94% stake in Minova Pharma from Hefei Lifeon Pharmaceutical Co., Ltd. for approximately CNY 32.1 million.	12/22/12	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021R	17/22/17	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	11/22/11	CI
Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hefei Lifeon Pharmaceutical Co., Ltd.

Equities

003020

CNE100004BD9

Highlights

Filters